Graft-versus-myeloma effects in reduced-intensity cord blood transplantation.
Miura, Yuji
Graft-versus-myeloma effects in reduced-intensity cord blood transplantation. [electronic resource] - International journal of hematology Dec 2007 - 463-5 p. digital
Publication Type: Letter
0925-5710
10.1007/BF02984008 doi
Aged
Busulfan--administration & dosage
Cord Blood Stem Cell Transplantation
Disease-Free Survival
Female
Graft Survival
Graft vs Host Disease--prevention & control
Graft vs Tumor Effect--drug effects
Humans
Immunosuppressive Agents--administration & dosage
Male
Middle Aged
Multiple Myeloma--mortality
Myeloablative Agonists--administration & dosage
Remission Induction
Retrospective Studies
Tacrolimus--administration & dosage
Time Factors
Transplantation Conditioning
Transplantation, Homologous
Vidarabine--administration & dosage
Graft-versus-myeloma effects in reduced-intensity cord blood transplantation. [electronic resource] - International journal of hematology Dec 2007 - 463-5 p. digital
Publication Type: Letter
0925-5710
10.1007/BF02984008 doi
Aged
Busulfan--administration & dosage
Cord Blood Stem Cell Transplantation
Disease-Free Survival
Female
Graft Survival
Graft vs Host Disease--prevention & control
Graft vs Tumor Effect--drug effects
Humans
Immunosuppressive Agents--administration & dosage
Male
Middle Aged
Multiple Myeloma--mortality
Myeloablative Agonists--administration & dosage
Remission Induction
Retrospective Studies
Tacrolimus--administration & dosage
Time Factors
Transplantation Conditioning
Transplantation, Homologous
Vidarabine--administration & dosage